15 8月 2018 by admin in UncategorizedComments Centrexion Therapeutics Appoints Dan Mendelson to its Board of Directors
15 8月 2018 by admin in UncategorizedComments resTORbio Appoints Jeffrey Chodakewitz, M.D., to its Board of Directors
14 8月 2018 by admin in UncategorizedComments Crescendo Biologics Reaches Technical Milestone for a Second Target in Strategic Collaboration with Takeda
07 8月 2018 by admin in UncategorizedComments Syros Reports Second Quarter 2018 Financial Results and Highlights Key Accomplishments and Upcoming Milestones
31 7月 2018 by admin in UncategorizedComments Syros to Report Second Quarter 2018 Financial Results on Tuesday, August 7, 2018
30 7月 2018 by admin in UncategorizedComments Centrexion Therapeutics Appoints Financial Executive Nick Harvey as Chief Financial Officer
25 7月 2018 by admin in UncategorizedComments resTORbio Announces Positive Topline Results in Phase 2b Trial of RTB101
11 7月 2018 by admin in UncategorizedComments resTORbio Announces Science Translational Medicine Publication of Phase 2a Data Showing Improvement in Immune Function and Decreased Infection Rates in People Aged 65 Years and Older
10 7月 2018 by admin in UncategorizedComments Syros to Host Key Opinion Leader Symposium on Acute Myeloid Leukemia and Myelodysplastic Syndrome on July 17, 2018
